Hemp stem extract countered BPA estrogen signaling in cells
Cannabis sativa L. stem ethanol extract suppresses ERα-mediated endocrine disrupting effects induced by bisphenol A in a breast cancer cell line.
AI Summary
This in vitro study asked whether an ethanol extract from Cannabis sativa stems could counteract the estrogen-receptor activity caused by bisphenol A (BPA). Researchers tested the extract in the human ERα-responsive VM7Luc4E2 breast cancer cell line, examining both ERα activation and cell proliferation. The abstract reports that the stem extract inhibited BPA-induced ERα transcriptional activation and suppressed cell proliferation.
The researchers also tested several compounds found in the extract. Cyclopentane-1,2-dione (CPD), 4-vinylguaiacol (4-VG), and 4-HMP each showed antagonistic activity against ERα activation and reduced proliferation in the cell model. The reported mechanisms differed: CPD blocked estrogen-induced ERα activation without significantly changing its movement into the nucleus, while 4-VG and 4-HMP appeared to act by reducing that nuclear translocation. The extract and compounds also reduced p38 phosphorylation in the MAPK signaling pathway. Because this was a laboratory cell study with no human participants or clinical outcomes, it cannot establish that hemp stems prevent endocrine disruption or provide a health benefit in people; this is an abstract-based summary, not a full-text review.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Cancer research papers you might find interesting.
CBD–epirubicin carrier reduced ovarian cancer cell viability in vitro
Turmeric-cannabis extract shows laboratory anti-inflammatory activity
Pilot trial links higher THC doses with anxiety and insomnia improvement
Explore More Research
Stay informed about the latest cannabis science.